DuoGenic StemCells corporation carries a market capitalization of 491.15M, placing it among publicly traded companies globally.
| Market Cap | 491.15M |
| Enterprise Value | N/A |
DuoGenic StemCells corporation's stock has gained approximately 29.4686% over the past 52 weeks. The 50-day moving average sits at 13.88, while the 200-day moving average is 16.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | 29.4686% |
| 50-Day Moving Average | 13.88 |
| 200-Day Moving Average | 16.27 |
| Average Volume (20 Days) | N/A |